Get In Touch with Helex Bio
Please tell us a little bit about yourself and why you'd like to get connected. Helex Bio + SOSV will follow up with you via email.
Team
Poulami Chaudhuri
Co-founder & CEO
Rohini Kalvakuntla
Chief Business Officer & Co-founder
Anirudh Nishtala
COO & Co-founder
Company details
Helex is driving synthetic RNA-driven therapeutics to solve rare genetic conditions by partnering with drug developers. The Helex Platform is powered by intelligent data-driven deep-learning modeling—using extensive high-throughput, next-generation sequencing data derived from CRISPR edits on human cell lines. Helex not only gives reliable predictions through the Helex Platform but also validates them in-house using cell-based assays and next-generation sequencing.
Company News
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.